Search - tctmd.com

Displaying 21 - 40 of 58

Sort: Relevancy | Date

Novel CEP Devices: Progress in Aortic Arch Deflector Devices

Presentation TVT 2023

Novel CEP Devices: Progress in Aortic Arch Deflector Devices

Presenter: Azeem Latib

June 09, 2023

Novel New CEP Devices: Progress in Debris Capture and Removal

Presentation TVT 2023

Novel New CEP Devices: Progress in Debris Capture and Removal

Presenter: Tamim Nazif

June 09, 2023

Position 2: The Trial Was Obviously Negative: Stop Wasting Money!

Presentation TVT 2023

Position 2: The Trial Was Obviously Negative: Stop Wasting Money!

Presenter: David Cohen

June 09, 2023

Has the Dust Settled After PROTECTED TAVR? Flash Review of the Results and What Will We Learn From the BHF-TAVI Study

Presentation TVT 2023

Has the Dust Settled After PROTECTED TAVR? Flash Review of the Results and What Will We Learn From the BHF-TAVI Study

Presenter: Samir Kapadia

June 09, 2023

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Presentation TVT 2023

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Presenter: Tamim Nazif

June 07, 2023

Cephea Implantation in Native Mitral Valve

Presentation Miami Valves 2023

Cephea Implantation in Native Mitral Valve

Presenter: Azeem Latib

February 04, 2023

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

News Features

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

October 17, 2022

New and Novel CEP Devices: Differentiating Features

Presentation TCT 2022

New and Novel CEP Devices: Differentiating Features

Presenter: Giora Weisz

September 17, 2022

The Journey of CEP from Clean TAVI to PROTECTED TAVR: Lessons Learned

Presentation TCT 2022

The Journey of CEP from Clean TAVI to PROTECTED TAVR: Lessons Learned

Presenter: Axel Linke

September 17, 2022

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

News Conference News TCT 2022

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

September 17, 2022

Defining My Wish-List for the Ideal CEP Device

Presentation TVT 2022

Defining My Wish-List for the Ideal CEP Device

Presenter: Giora Weisz

June 10, 2022

The Cephea Trans-septal System: EFS Program Update

Presentation TVT 2022

The Cephea Trans-septal System: EFS Program Update

Presenter: Vinod H. Thourani

June 10, 2022

COVID-19: TCTMD’s Dispatch for March Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for March Week 2

March 07, 2022

CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices

News Conference News STS 2022

CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices

February 03, 2022

Conversations in Cardiology: Do You Use Antibiotics in the Cath Lab?

News Opinion Conversations in Cardiology

Conversations in Cardiology: Do You Use Antibiotics in the Cath Lab?

October 12, 2021

COVID-19: TCTMD’s Daily Dispatch for September Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September Week 2

September 08, 2021

Transseptal III: Cephea — Device Description, Results, and Ongoing Studies

Presentation TCT 2019

Transseptal III: Cephea — Device Description, Results, and Ongoing Studies

Presenter: Thomas Modine

September 28, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

Debate Cerebral Embolic Protection: The Data are Compelling and the Costs Manageable

Presentation SIF 2019

Debate Cerebral Embolic Protection: The Data are Compelling and the Costs Manageable

Presenter: Saif Anwaruddin

March 30, 2019

Mind Doesn’t Know What the Eye Can’t See: Unconscious Biases in Cardiothoracic Surgery

News Conference News STS 2019

Mind Doesn’t Know What the Eye Can’t See: Unconscious Biases in Cardiothoracic Surgery

Yael L. Maxwell

January 30, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.